NKGen Biotech to present long-term Alzheimer’s therapy follow-up at CTAD
Nkgen Biotech will present a poster at the 19th Clinical Trials on Alzheimer’s Disease conference, taking place on 16-19 November 2026, in Boston and virtually. The poster, titled Long-Term Cognitive Benefit of Troculeucel NK Cell Therapy in a Patient With Moderate Alzheimer’s Disease: A Single-Subj
<p>Nkgen Biotech will present a poster at the 19th Clinical Trials on Alzheimer’s Disease conference, taking place on 16-19 November 2026, in Boston and virtually. The poster, titled Long-Term Cognitive Benefit of Troculeucel NK Cell Therapy in a Patient With Moderate Alzheimer’s Disease: A Single-Subj</p>